Subscribe
william_potter
william_potter / iStockphoto.com
31 October 2018Big Pharma

Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition

Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Japanese Takeda to acquire Shire for $62bn
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Asia-Pacific
Takeda makes fourth offer to buy Shire
23 April 2018   Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.
Big Pharma
EUIPO sides with Takeda in trademark appeal
28 November 2018   Japan-based Takeda Pharmaceutical has persuaded the European Union Intellectual Property Office that an applied-for trademark would be confused with its own earlier-registered mark


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Big Pharma
Japanese Takeda to acquire Shire for $62bn
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Asia-Pacific
Takeda makes fourth offer to buy Shire
23 April 2018   Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.
Big Pharma
EUIPO sides with Takeda in trademark appeal
28 November 2018   Japan-based Takeda Pharmaceutical has persuaded the European Union Intellectual Property Office that an applied-for trademark would be confused with its own earlier-registered mark

More on this story

Big Pharma
Japanese Takeda to acquire Shire for $62bn
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Asia-Pacific
Takeda makes fourth offer to buy Shire
23 April 2018   Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.
Big Pharma
EUIPO sides with Takeda in trademark appeal
28 November 2018   Japan-based Takeda Pharmaceutical has persuaded the European Union Intellectual Property Office that an applied-for trademark would be confused with its own earlier-registered mark

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York